$76.65
1.33 (-1.71%)
Last updated: Jul 19, 2026 18:30
Fundamentals Overview
DexCom, Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Intrinsic value (DCF)
-40% downside vs price
Profitability
Risk (Beta)
1.45 — higher vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Analyst grade: B+ · 3M vs S&P 500: +18.4% · 3M vs Healthcare sector: +15.5%
Pressures (Sell):
DCF 40% downside vs price · Beta 1.45 (elevated)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B+. Recent institutional grades: mixed. Current institutional positions: Buy: 17, Equal Weight: 1, Outperform: 5, Overweight: 3, Underweight: 4.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $46.01; current price is $76.65. That’s a -40% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 32.43 |
| DCF value (model) | $46.01 (-40% vs price) |
| PEG (TTM) | 0.44 |
| P/B (TTM) | 9.98 |
| P/S (TTM) | 6.14 |
| P/FCF (TTM) | 20.69 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.95 |
| Quick Ratio (TTM) | 1.64 |
| Cash Ratio (TTM) | 0.5 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 19.31% |
| Gross margin (TTM) | 61.84% |
| Operating margin (TTM) | 21.45% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for DXCM.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Truist Securities | maintain | Buy | Buy | 2026-07-16 |
| Mizuho | maintain | Outperform | Outperform | 2026-07-15 |
| Deutsche Bank | maintain | Buy | Buy | 2026-06-23 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-06-15 |
| TD Cowen | maintain | Buy | Buy | 2026-06-10 |
| Mizuho | maintain | Outperform | Outperform | 2026-06-09 |
| Stifel | maintain | Buy | Buy | 2026-06-05 |
| Citigroup | maintain | Buy | Buy | 2026-05-28 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-05-18 |
| B of A Securities | maintain | Buy | Buy | 2026-05-18 |
| Barclays | maintain | Underweight | Underweight | 2026-05-18 |
| Citigroup | maintain | Buy | Buy | 2026-05-04 |
| TD Cowen | maintain | Buy | Buy | 2026-05-01 |
| Barclays | maintain | Underweight | Underweight | 2026-05-01 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-05-01 |
| Citigroup | maintain | Buy | Buy | 2026-03-11 |
| BTIG | maintain | Buy | Buy | 2026-03-09 |
| BTIG | maintain | Buy | Buy | 2026-02-25 |
| Truist Securities | maintain | Buy | Buy | 2026-02-17 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-02-13 |
| Mizuho | maintain | Outperform | Outperform | 2026-02-13 |
| Wells Fargo | maintain | Overweight | Overweight | 2026-02-13 |
| BTIG | maintain | Buy | Buy | 2026-02-13 |
| Barclays | maintain | Underweight | Underweight | 2026-02-13 |
| Barclays | downgrade | Equal Weight | Underweight | 2026-01-12 |
| Bernstein | maintain | Outperform | Outperform | 2026-01-09 |
| Mizuho | maintain | Outperform | Outperform | 2025-12-17 |
| Citigroup | maintain | Buy | Buy | 2025-12-11 |
| Morgan Stanley | upgrade | Equal Weight | Overweight | 2025-12-02 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-11-10 |